|
Volumn 31, Issue 1, 2005, Pages 58-62
|
Gabapentin significantly improves analgesia in people receiving opioids for neuropathic cancer pain
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GABAPENTIN;
OPIATE;
ABDOMINAL PAIN;
ADULT;
ALLODYNIA;
ANALGESIA;
CANCER;
CANCER INFILTRATION;
CANCER PAIN;
CANCER PATIENT;
CLINICAL TRIAL;
CONSCIOUSNESS DISORDER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DIZZINESS;
DRUG ERUPTION;
DYSESTHESIA;
FEMALE;
HEADACHE;
HUMAN;
INCONTINENCE;
INFECTION;
INTESTINE OBSTRUCTION;
JAW;
LIFE EXPECTANCY;
MAJOR CLINICAL STUDY;
MALAISE;
MALE;
MULTICENTER STUDY;
MUSCLE CRAMP;
NAUSEA AND VOMITING;
NERVE COMPRESSION;
NEUROPATHIC PAIN;
PAIN ASSESSMENT;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATION DEPRESSION;
RESTLESSNESS;
SHORT SURVEY;
SKIN DEFECT;
SOFT TISSUE DISEASE;
SUBARACHNOID HEMORRHAGE;
SWEAT GLAND DISEASE;
TREMOR;
VERTIGO;
|
EID: 13844266548
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ctrv.2004.12.001 Document Type: Note |
Times cited : (9)
|
References (10)
|